BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,280
-820 (-5.43%)
At close: Feb 6, 2026
-34.19%
Market Cap454.78B -28.8%
Revenue (ttm)165.64B +27.8%
Net Income-7.70B
EPS-242.14
Shares Out31.85M
PE Ration/a
Forward PE119.16
Dividendn/a
Ex-Dividend Daten/a
Volume244,466
Average Volume347,186
Open14,780
Previous Close15,100
Day's Range14,220 - 14,780
52-Week Range12,800 - 22,900
Beta0.76
RSI42.57
Earnings DateMar 13, 2026

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 650
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements